162 related articles for article (PubMed ID: 36580233)
1. Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma.
Zhou Y; He X; Jiang Y; Wang Z; Yu Y; Wu W; Zhang C; Li J; Guo Y; Chen X; Liu Z; Zhao J; Liu K; Dong Z
Front Med; 2023 Apr; 17(2):290-303. PubMed ID: 36580233
[TBL] [Abstract][Full Text] [Related]
2. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
[TBL] [Abstract][Full Text] [Related]
3. Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.
Song M; Qu Y; Jia H; Zhang Y; Liu S; Laster KV; Choi BY; Tian J; Gu T; Chen H; Liu K; Lee MH; Dong Z
Mol Carcinog; 2024 May; 63(5):991-1008. PubMed ID: 38376345
[TBL] [Abstract][Full Text] [Related]
4. Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3.
Hu Y; Liu F; Jia X; Wang P; Gu T; Liu H; Liu T; Wei H; Chen H; Zhao J; Yang R; Chen Y; Dong Z; Liu K
Oncogene; 2021 Jun; 40(23):3942-3958. PubMed ID: 33986510
[TBL] [Abstract][Full Text] [Related]
5. Diosmetin suppresses the progression of ESCC by CDK2/Rb/E2F2/RRM2 pathway and synergies with cisplatin.
Chen Y; Dai X; Chen W; Qiao Y; Bai R; Duan X; Zhang K; Chen X; Li X; Mo S; Cao W; Li X; Liu K; Dong Z; Lu J
Oncogene; 2023 Jul; 42(29):2278-2293. PubMed ID: 37349644
[TBL] [Abstract][Full Text] [Related]
6. Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo.
Xie X; Zu X; Liu F; Wang T; Wang X; Chen H; Liu K; Wang P; Liu F; Zheng Y; Bode AM; Dong Z; Kim DJ
Mol Carcinog; 2019 Jul; 58(7):1248-1259. PubMed ID: 31100197
[TBL] [Abstract][Full Text] [Related]
7. Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma.
Liu F; Zu X; Xie X; Zhang Y; Liu K; Chen H; Wang T; Bode AM; Dong Z; Kim DJ
Cancer Prev Res (Phila); 2019 Dec; 12(12):849-860. PubMed ID: 31554627
[TBL] [Abstract][Full Text] [Related]
8. Daurisoline suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting MEK1/2 kinase.
Wang D; Zhang W; Zhang X; Li M; Wu Q; Li X; Zhao L; Yuan Q; Yu Y; Lu J; Zhao J; Dong Z; Liu K; Jiang Y
Mol Carcinog; 2023 Apr; 62(4):517-531. PubMed ID: 36645220
[TBL] [Abstract][Full Text] [Related]
9. Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase.
Yang N; Lu X; Jiang Y; Zhao L; Wang D; Wei Y; Yu Y; Kim MO; Laster KV; Li X; Yuan B; Dong Z; Liu K
Elife; 2022 Sep; 11():. PubMed ID: 36082941
[TBL] [Abstract][Full Text] [Related]
10. Corynoline inhibits esophageal squamous cell carcinoma growth via targeting Pim-3.
Shi Y; Yuan Q; Chen Y; Li X; Zhou Y; Zhou H; Peng F; Jiang Y; Qiao Y; Zhao J; Zhang C; Wang J; Liu K; Dong Z
Phytomedicine; 2024 Jan; 123():155235. PubMed ID: 38128397
[TBL] [Abstract][Full Text] [Related]
11. miR-200b induces cell cycle arrest and represses cell growth in esophageal squamous cell carcinoma.
Zhang HF; Alshareef A; Wu C; Jiao JW; Sorensen PH; Lai R; Xu LY; Li EM
Carcinogenesis; 2016 Sep; 37(9):858-869. PubMed ID: 27496804
[TBL] [Abstract][Full Text] [Related]
12. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
Bolidong D; Domoto T; Uehara M; Sabit H; Okumura T; Endo Y; Nakada M; Ninomiya I; Miyashita T; Wong RW; Minamoto T
Sci Rep; 2020 Jul; 10(1):11807. PubMed ID: 32678196
[TBL] [Abstract][Full Text] [Related]
13. Deoxypodophyllotoxin, a Lignan from
Kwak AW; Lee MH; Yoon G; Cho SS; Choi JS; Chae JI; Shim JH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961992
[TBL] [Abstract][Full Text] [Related]
14. Dasabuvir suppresses esophageal squamous cell carcinoma growth in vitro and in vivo through targeting ROCK1.
Liu X; Jiang Y; Zhou H; Zhao X; Li M; Bao Z; Wang Z; Zhang C; Xie Z; Zhao J; Dong Z; Liu K; Guo Z
Cell Death Dis; 2023 Feb; 14(2):118. PubMed ID: 36781836
[TBL] [Abstract][Full Text] [Related]
15. Pristimerin targeting NF-κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells.
Tu Y; Tan F; Zhou J; Pan J
Cell Biochem Funct; 2018 Jun; 36(4):228-240. PubMed ID: 29781107
[TBL] [Abstract][Full Text] [Related]
16. Ixazomib Induces Apoptosis and Suppresses Proliferation in Esophageal Squamous Cell Carcinoma through Activation of the c-Myc/NOXA Pathway.
Wang T; Zhang P; Chen L; Qi H; Chen H; Zhu Y; Zhang L; Zhong M; Shi X; Li Q
J Pharmacol Exp Ther; 2022 Jan; 380(1):15-25. PubMed ID: 34740946
[TBL] [Abstract][Full Text] [Related]
17. Targeting integrin αvβ3 with indomethacin inhibits patient-derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma.
Liu F; Wu Q; Han W; Laster K; Hu Y; Ma F; Chen H; Tian X; Qiao Y; Liu H; Kim DJ; Dong Z; Liu K
Clin Transl Med; 2021 Oct; 11(10):e548. PubMed ID: 34709754
[TBL] [Abstract][Full Text] [Related]
18. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762.
Wang JN; Che Y; Yuan ZY; Lu ZL; Li Y; Zhang ZR; Li N; Li RD; Wan J; Sun HD; Sun N; Puno PT; He J
Toxicol Appl Pharmacol; 2019 Feb; 365():71-83. PubMed ID: 30633885
[TBL] [Abstract][Full Text] [Related]
19. SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.
Barzegar M; Ma S; Zhang C; Chen X; Gu Y; Shang C; Jiang X; Yang J; Nathan CA; Yang S; Huang S
Br J Cancer; 2017 Oct; 117(8):1154-1163. PubMed ID: 28873083
[TBL] [Abstract][Full Text] [Related]
20. Novel carbazole sulfonamide microtubule-destabilizing agents exert potent antitumor activity against esophageal squamous cell carcinoma.
Niu F; Liu Y; Jing Z; Han G; Sun L; Yan L; Zhou L; Wu Y; Xu Y; Hu L; Zhao X
Cancer Lett; 2018 Apr; 420():60-71. PubMed ID: 29408653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
